SCHEMBL3847017

SCHEMBL3847017

O=[N+]([O-])c1ccc(-c2ccn(C(c3ccccc3)(c3ccccc3)c3ccccc3)n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
THRB P10828 1/20 0.47
SCN4A P35499 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MAOB P27338 1/20 0.42
AR P10275 1/20 0.41
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 2/20 0.41
CYP19A1 P11511 1/20 0.41
LMNA P02545 1/20 0.41
MBD2 Q9UBB5 1/20 0.40
POLB P06746 1/20 0.40
MAPK1 P28482 1/20 0.40
PKM P14618 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
NFKB1 P19838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5800759 0.82 KMT2A (0.52) MEN1KMT2ASCN4ANPC1RAB9A
SCHEMBL4313599 0.80 SCN4A (0.48) KMT2ASCN4ANPC1RAB9AMAOB
SCHEMBL3846751 0.78 KMT2A (0.44) MEN1KMT2ANPC1RAB9AALDH1A1
SCHEMBL3847283 0.77 KIF11 (0.47) KMT2AMAOBALDH1A1CYP19A1ADORA2A
SCHEMBL9404829 0.76 DYRK1A (0.42) MEN1KMT2ANPC1RAB9AMAOB
SCHEMBL3848019 0.75 KMT2A (0.47) MEN1KMT2ATHRBALDH1A1SMN1; SMN2
SCHEMBL3846623 0.74 KMT2A (0.34) KMT2ASCN4ANPC1RAB9ASMN1; SMN2
SCHEMBL4629018 0.72 KEAP1 (0.55) KMT2ASCN4ANPC1RAB9AALDH1A1
SCHEMBL3846757 0.72 SCN5A (0.48) NPC1RAB9AALDH1A1MAPTMAPK1
SCHEMBL3847454 0.71 MAOB (0.40) KMT2ARAB9AMAOBALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed